New York, New York - June 21, 2012 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), one of the NASDAQ’s top gainers, trading at $62.18, up $17.60 or (39.48%) as of 11:14AM EDT on over 16 Million shares. The stock has a morning high of $63.22.
The Company announced yesterday that the U.S. FDA's Oncologic Drugs
Advisory Committee (ODAC) determined by a vote of 11-0 [with 1
abstention] that, in patients with relapsed and refractory multiple
myeloma who have received at least two prior lines of therapy that
included a proteasome inhibitor and an immunomodulatory agent (IMiD),
the benefit-risk assessment is favorable for the use of Kyprolis�
(proposed brand name for carfilzomib). Onyx is developing Kyprolis for
use in multiple myeloma across a variety of treatment lines.
About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving
the lives of people with cancer. The company is focused on developing
novel medicines that target key molecular pathways. For more information
about Onyx, visit the company's website at www.onyx.com.
InvestorIdeas.com is a leader
in investor stock research by sector. Sectors we cover include; water
and renewable energy stocks, biotech stocks, mining and gold stocks,
energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/ Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/ Investorideas
Sign up for the free investor news and stock alerts at Investorideas.com
Research biotech stocks at the Biotech stocks Directory and biotech news and research at www.biotechindustrystocks.com
Become an Investorideas.com Member
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure :
The Investorideas.com is a third party publisher of news and research
Our sites do not make recommendations, but offer information portals to
research news, articles, stock lists and recent research. Nothing on our
sites should be construed as an offer or solicitation to buy or sell
products or securities. This site is currently compensated by featured
companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies
for adherence in new disclosure filings and filing appropriate documents
with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - www.Investorideas.com